US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jun 24, 2022 (4 years ago)

Daytrana

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.

What was recalled

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186. NDC 68968-5552-3

Recalling firm
Noven Pharmaceuticals Inc
NDC code
68968-5552-3
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1169-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methylphenidate recalls

See all
Class III · Low risk Ongoing

Focalin XR

Reason Labeling: Incorrect or Missing Lot and/or Exp Date

Sandoz Inc D-0608-2026
Class II · Moderate risk Terminated

Methylphenidate Hydrochloride

Reason Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.

Trigen Laboratories NDC 13811-708-10 D-0579-2024
Class II · Moderate risk Terminated

Methylphenidate Hydrochloride Tablets

Reason Presence of Foreign Substance: Metal embedded in a tablet.

Sun Pharmaceutical Industries INC NDC 57664-230-88 D-0940-2023
Class II · Moderate risk Ongoing

Daytrana

Reason Defective Delivery System: Out of specification for shear.

Noven Pharmaceuticals Inc NDC 68968-5555-3 D-0473-2023
Class II · Moderate risk Ongoing

Daytrana

Reason Defective Delivery System: Out of specification for shear.

Noven Pharmaceuticals Inc NDC 68968-5554-3 D-0472-2023